收费全文 | 2021篇 |
免费 | 126篇 |
国内免费 | 12篇 |
耳鼻咽喉 | 12篇 |
儿科学 | 51篇 |
妇产科学 | 43篇 |
基础医学 | 358篇 |
口腔科学 | 27篇 |
临床医学 | 176篇 |
内科学 | 485篇 |
皮肤病学 | 63篇 |
神经病学 | 216篇 |
特种医学 | 30篇 |
外科学 | 105篇 |
综合类 | 33篇 |
一般理论 | 1篇 |
预防医学 | 198篇 |
眼科学 | 64篇 |
药学 | 151篇 |
中国医学 | 6篇 |
肿瘤学 | 140篇 |
2024年 | 3篇 |
2023年 | 19篇 |
2022年 | 53篇 |
2021年 | 104篇 |
2020年 | 58篇 |
2019年 | 81篇 |
2018年 | 81篇 |
2017年 | 47篇 |
2016年 | 67篇 |
2015年 | 80篇 |
2014年 | 112篇 |
2013年 | 127篇 |
2012年 | 173篇 |
2011年 | 163篇 |
2010年 | 94篇 |
2009年 | 62篇 |
2008年 | 136篇 |
2007年 | 121篇 |
2006年 | 122篇 |
2005年 | 97篇 |
2004年 | 74篇 |
2003年 | 87篇 |
2002年 | 80篇 |
2001年 | 14篇 |
2000年 | 9篇 |
1999年 | 2篇 |
1998年 | 5篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1995年 | 11篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1988年 | 3篇 |
1986年 | 5篇 |
1985年 | 2篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1968年 | 3篇 |
1966年 | 1篇 |
1962年 | 1篇 |
Purpose
Almonds have shown to beneficially modify some cardiovascular risk factors in clinical trials conducted in diverse ethnic populations but this relationship has never been tested in Koreans. Thus, we tested the impact of almonds consumed as a snack within the context of a typical Korean diet on cardiovascular risk factors.Methods
We conducted a randomized, crossover trial in a free-living setting with a 2-week run-in period, two 4-week intervention phases, and a 2-week washout period between interventions. Eighty four overweight/obese participants (11 M/73 F; 52.4 ± 0.6 year; 25.4 ± 0.22 kg/m2) consumed either 56 g of almonds or isocaloric cookies daily for 4 weeks.Results
Mean % daily energy intake at baseline was 64.8, 21.3, and 14.9% from carbohydrate, fat, and protein, respectively. The addition of 56 g of almonds daily decreased carbohydrate energy to 55.0%, increased fat to 32.0%, and maintained protein at 14.7%. Consuming the almonds increased intake of MUFA by 192.3%, PUFA by 84.5%, vitamin E by 102.7%, and dietary fiber by 11.8% and decreased % energy from carbohydrate by 14.1%. Total caloric intake was increased by the almonds, but body weight, waist circumference, and body composition were not affected. Almonds in overweight and obese Korean adults decreased TC, LDL-C, and non-HDL-C by 5.5, 4.6, and 6.4%, respectively, compared to the cookie control (P ≤ 0.05). Almonds increased plasma α-tocopherol by 8.5% (P ≤ 0.05) from the baseline and tended to increase its value as compared to cookies (P = 0.055). Neither the almonds nor cookies altered plasma protein carbonyls, MDA or oxLDL. Of serum inflammatory markers, IL-10 was decreased by almond intake (P ≤ 0.05), and ICAM-1, IL-1β, and IL-6 tended to be lower with almonds, compared to the cookies.Conclusions
Almonds at 56 g/day consumed as a snack favorably modified the Korean diet by increasing MUFA, PUFA, vitamin E, and dietary fiber intake and decreasing % energy intake from carbohydrate. Almonds also enhanced plasma α-tocopherol status and serum TC and LDL-C in overweight and obese Koreans. Thus, including almonds in typical Korean diets as a snack can help healthy overweight/obese individuals improve nutritional status and reduce their risk for CVD.Specifically, we sought to test whether GHWs that portray specific groups (in terms of gender, race, and chronic disease conditions) are associated with differences in risk perception and intention to quit among smokers who match the portrayed group. We used data from Project CLEAR, which oversampled lower SES groups as well as race/ethnic minority groups living in the Greater Boston area (n = 565). We fitted multiple linear regression models to examine the impact of exposure to different GHWs on risk perceptions and quit intentions. After controlling for age, gender, education and household income, we found that women who viewed GHWs portraying females reported increased risk perception as compared to women who viewed GHWs portraying men. However, no other interactions were found between the groups depicted in GHWs and audience characteristics. The findings suggest that audience segmentation of GHWs may have limited impact on risk perceptions and intention to quit smoking among adult smokers. 相似文献
Background
Ifenprodil as a specific antagonist of NMDA receptors containing a dominant NR2B subunit exhibits age-dependent anticonvulsant action. Possible changes of this action due to status epilepticus (SE) elicited at early stage of development were studied using cortical epileptic afterdischarges (ADs) as a model.Methods
Lithium-pilocarpine SE was induced at postnatal day 12 and effects of ifenprodil were studied 3, 6, 9, and 13?days after SE in rat pups with implanted epidural electrodes. Controls (LiPAR) received saline instead of pilocarpine. ADs were elicited by low frequency stimulation of sensorimotor cortex. Intensity of stimulation current increased in 18 steps from 0.2 to 15?mA. Ifenprodil (20?mg/kg) was administered intraperitoneally (ip) after the stimulation with 3.5-mA current. Threshold for four different phenomena as well as duration of ADs were evaluated.Results
The threshold for the transition into the limbic type of ADs was higher in 15-day-old SE rats than in LiPAR controls. Opposite difference was found in 18-day-old animals, older rats did not exhibit any difference. Isolated significant changes in total duration of ADs were found after high stimulation intensities. These changes appeared in 18-day-old rats where ADs were shorter in SE than in control LiPAR rats.Conclusions
Changes in ifenprodil action were found only in the first week after SE but not in the second week. Interpretation of the results is complicated by failure of significant differences between SE and LiPAR rats probably due to a high dose of paraldehyde. 相似文献- IMPLICATIONS FOR REHABILITATION
As youth and young adults with cerebral palsy age, options for mobilization can become limited with challenges in placing them in a walking device due to size and numerous other physical limitations.
A robotic walker with a built-in mechanical lift is available for individuals with cerebral palsy.
This study was able to gather important information and recommendations to tailor a new robotic walker prototype specifically for individuals with cerebral palsy.